236 related articles for article (PubMed ID: 18992359)
1. Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii.
Lee P; Abdul-Wahid A; Faubert GM
Microbes Infect; 2009 Jan; 11(1):20-8. PubMed ID: 18992359
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization of BALB/c mice by intragastric delivery of Streptococcus gordonii-expressing Giardia cyst wall protein 2 decreases cyst shedding in challenged mice.
Lee P; Faubert GM
FEMS Microbiol Lett; 2006 Dec; 265(2):225-36. PubMed ID: 17081198
[TBL] [Abstract][Full Text] [Related]
3. Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle.
Abdul-Wahid A; Faubert G
Vaccine; 2007 Dec; 25(50):8372-83. PubMed ID: 17996337
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization of BALB/c mice with Giardia duodenalis recombinant cyst wall protein inhibits shedding of cysts.
Larocque R; Nakagaki K; Lee P; Abdul-Wahid A; Faubert GM
Infect Immun; 2003 Oct; 71(10):5662-9. PubMed ID: 14500486
[TBL] [Abstract][Full Text] [Related]
5. Expression of the Giardia lamblia cyst wall protein 2 in Lactococcus lactis.
Lee P; Faubert GM
Microbiology (Reading); 2006 Jul; 152(Pt 7):1981-1990. PubMed ID: 16804173
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the local immune response to cyst antigens during the acute and elimination phases of primary murine giardiasis.
Abdul-Wahid A; Faubert G
Int J Parasitol; 2008 May; 38(6):691-703. PubMed ID: 18037419
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with Bivalent DNA Vaccine of α1-Giardin and CWP2 Delivered by Attenuated Salmonella typhimurium Reduces Trophozoites and Cysts in the Feces of Mice Infected with Giardia lamblia.
Feng XM; Zheng WY; Zhang HM; Shi WY; Li Y; Cui BJ; Wang HY
PLoS One; 2016; 11(6):e0157872. PubMed ID: 27332547
[TBL] [Abstract][Full Text] [Related]
9. Identification of Conserved Candidate Vaccine Antigens in the Surface Proteome of Giardia lamblia.
Davids BJ; Liu CM; Hanson EM; Le CHY; Ang J; Hanevik K; Fischer M; Radunovic M; Langeland N; Ferella M; Svärd SG; Ghassemian M; Miyamoto Y; Eckmann L
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30962402
[No Abstract] [Full Text] [Related]
10. Systemic and local antibody response in mice induced by a recombinant peptide fragment from Giardia lamblia variant surface protein (VSP) H7 produced by a Salmonella typhimurium vaccine strain.
Stäger S; Gottstein B; Müller N
Int J Parasitol; 1997 Aug; 27(8):965-71. PubMed ID: 9292314
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.
Moorthy SA; Yasawardena SG; Ramasamy R
Vaccine; 2009 Aug; 27(36):4947-52. PubMed ID: 19545652
[TBL] [Abstract][Full Text] [Related]
12. Cytokines, Antibodies, and Histopathological Profiles during Giardia Infection and Variant-Specific Surface Protein-Based Vaccination.
Serradell MC; Gargantini PR; Saura A; Oms SR; Rupil LL; Berod L; Sparwasser T; Luján HD
Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29555679
[TBL] [Abstract][Full Text] [Related]
13. Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model.
Jenikova G; Hruz P; Andersson MK; Tejman-Yarden N; Ferreira PC; Andersen YS; Davids BJ; Gillin FD; Svärd SG; Curtiss R; Eckmann L
Vaccine; 2011 Nov; 29(51):9529-37. PubMed ID: 22001876
[TBL] [Abstract][Full Text] [Related]
14. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein.
Taghinezhad-S S; Mohseni AH; Keyvani H; Razavilar V
Microb Pathog; 2019 Jan; 126():149-156. PubMed ID: 30391536
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
[TBL] [Abstract][Full Text] [Related]
16. Recombinant lactococcus lactis expressing Eimeria tenella AMA1 protein and its immunological effects against homologous challenge.
Li J; Wang F; Ma C; Huang Y; Wang D; Ma D
Exp Parasitol; 2018 Aug; 191():1-8. PubMed ID: 29890444
[TBL] [Abstract][Full Text] [Related]
17. Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.
Rashid I; Hedhli D; Moiré N; Pierre J; Debierre-Grockiego F; Dimier-Poisson I; Mévélec MN
Vaccine; 2011 Nov; 29(48):8838-46. PubMed ID: 21983362
[TBL] [Abstract][Full Text] [Related]
18. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
19. Administration of kefir-fermented milk protects mice against Giardia intestinalis infection.
Franco MC; Golowczyc MA; De Antoni GL; Pérez PF; Humen M; Serradell MLA
J Med Microbiol; 2013 Dec; 62(Pt 12):1815-1822. PubMed ID: 24072759
[TBL] [Abstract][Full Text] [Related]
20. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
